Home > Pulmonology > ATS 2023

ATS 2023


American Thoracic Society 19–24 May 2023 Washington DC, USA

Table of Contents



TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH

Presented By
Prof. Robert Frantz, Mayo Clinic, MN, USA

Practice-changing results for ensifentrine in COPD

Presented By
Prof. Antonio Anzueto, University of Texas Health San Antonio, TX, USA

Asthma

Vitamin D for asthma protection: what is the optimal timing?

Presented By
Dr Lourdes Ramirez, Brigham and Women’s Hospital, MA, USA

Remarkable results for novel biologic therapy for asthma

Presented By
Dr Benjamin Suratt, Sanofi, NJ, USA

Success for fluticasone furoate plus vilanterol in uncontrolled asthma

Presented By
Dr Philippe Bareille, GSK, UK

COPD

Practice-changing results for ensifentrine in COPD

Presented By
Prof. Antonio Anzueto, University of Texas Health San Antonio, TX, USA

Alvelestat for AATD meets primary endpoints in phase 2 trial

Presented By
Prof. Robert Stockley, University Hospital Birmingham, UK

Fewer exacerbations with dupilumab in COPD with type 2 inflammation

Presented By
Prof. Klaus Rabe, LungenClinic Grosshansdorf GmbH, Germany

New AATD therapy may alleviate treatment burden for patients

Presented By
Dr Brooks Kuhn, UC Davis School of Medicine, CA, USA

Efficient detection of AECOPD with at-home vital signs monitoring

Presented By
Mr Yann Le Guillou, Biosency, France

COVID-19

COVA trial: success for the investigational agent sarconeos in hospitalised COVID-19

Presented By
Dr Girish Balachandran Nair, Beaumont Hospital, MI, USA

Mitochondrial DNA levels predict COVID-19 severity

Presented By
Dr Marlene Cano, Washington University in Saint Louis, MO, USA

Other

Excellent results for C21 in idiopathic pulmonary fibrosis

Presented By
Prof. Toby Maher , Keck School of Medicine of USC, USA

Can camlipixant improve quality of life of patients with refractory chronic cough?

Presented By
Dr Lorcan McGarvey, Queen’s University Belfast, UK

TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH

Presented By
Prof. Robert Frantz, Mayo Clinic, MN, USA

Improving quality care in sepsis through machine learning models

Presented By
Dr Elizabeth Munroe, University of Michigan, MI, USA

Can information technology improve guideline adherence in sepsis care?

Presented By
Dr Daniel Leisman, Massachusetts General Hospital, MA, USA
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com